Firefly Neuroscience (AIFF) vs Aware (AWRE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aware (AWRE) has outperformed Firefly Neuroscience (AIFF) over the past year, losing 57.7% versus a loss of 60.3%. Over five years, AWRE leads with a -73.9% price change compared with -98.7% for AIFF. Aware is the larger company by market cap ($22.6 million vs $18.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIFF | AWRE |
|---|---|---|
| Share price | $1.19 | $1.04 |
| Market cap | $18.59M | $22.58M |
| 1-day change | -2.07% | -0.48% |
| YTD return | +37.50% | -43.78% |
| 1-year return | -60.33% | -57.72% |
| 5-year return | -98.72% | -73.87% |
| EPS (TTM) | $-0.59 | $-0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.15 | $2.62 |
| 52-week low | $0.62 | $1.02 |
| Distance from 52-week high | -62.38% | -60.50% |
| Average volume | 2.68M | 37.97K |
| Shares outstanding | 15.69M | 21.81M |
| Employees | 17 | 80 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Firefly Neuroscience
AIFF stock →Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury.
Technology · Computer Software: Prepackaged Software · 17 employees
About Aware
AWRE stock →Aware, Inc., a biometric identity platform company, provides biometrics software products and services for government agencies and commercial entities in the United States, the United Kingdom, and internationally. The company offers biometric software solution, including AwareID, a software-as-a-service that provides identity verification and continuous authentication capabilities; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification, as well as AFIX Face, AFIX Verifier, AFIX Identifier, AFIX Comparator, AFIX Engine, and AFIX NIST Transaction Engine.
Technology · Computer Software: Prepackaged Software · 80 employees
AIFF vs AWRE FAQ
Which is bigger, Firefly Neuroscience or Aware?
Aware (AWRE) is larger, with a market capitalization of $22.58M compared with $18.59M for Firefly Neuroscience (AIFF).
Which stock has performed better over the past year, AIFF or AWRE?
AWRE returned -57.72% over the past 12 months, compared with -60.33% for AIFF (price return, excluding dividends). Past performance does not predict future results.
Are Firefly Neuroscience and Aware in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.